Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Wanping Xu, Ph.D.

Program Director

Division of Cancer Biology (DCB)

Cancer Cell Biology Branch

240-858-3957

wx10g@nih.gov

Dr. Wanping Xu manages a portfolio of grants focusing on cancer cachexia biological pathways, cancer signaling pathways, and cellular chaperones.

Dr. Xu is interested in new technologies and approaches that have enabled scientists to understand the dynamic and translocation processes in cell signaling.

Background

Prior to DCB, he was a staff scientist at the NCI Center for Cancer Research (CCR) where he studied heat shock protein 90 (Hsp90).

Education

Ph.D, Molecular and Cellular Biology, University of Maryland- Baltimore